Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
73 studies found for:    "Mumps"
Show Display Options
Rank Status Study
1 Completed Immunogenicity & Safety Study of GSK Biologicals' Combined Measles-mumps-rubella-varicella Vaccine 208136
Conditions: Rubella;   Varicella;   Mumps;   Measles;   Measles-Mumps-Rubella-Varicella Vaccine
Interventions: Biological: PriorixTM;   Biological: VarilrixTM;   Biological: GSK Biologicals' vaccine 208136
2 Completed Comparison of GSK Measles-mumps-rubella-varicella (MMRV) Vaccine Versus PriorixTM
Conditions: Rubella;   Varicella;   Mumps;   Measles
Interventions: Biological: GSK Biological's investigational MMRV vaccine 208136;   Biological: Priorix™;   Biological: Varilrix™
3 Unknown  Comparative Study of the Immunogenicity of MMR (Measles, Mumps and Rubella) Single Dose and Multidose Presentations
Conditions: Measles;   Mumps;   Rubella
Intervention: Biological: MMR Vaccine
4 Completed
Has Results
Study of Japanese Encephalitis Chimeric Virus Vaccine Given With Measles-Mumps-Rubella Vaccine in Taiwanese Toddlers
Conditions: Japanese Encephalitis;   Measles;   Mumps;   Rubella
Intervention: Biological: Japanese encephalitis chimeric virus: Measles, mumps, and rubella live attenuated virus
5 Recruiting Immunogenicity and Safety of GSK Biologicals' Combined Measles-mumps-rubella Vaccine in Volunteers, Seven Years of Age and Older
Conditions: Rubella;   Mumps;   Measles
Interventions: Biological: Priorix®;   Biological: Merck's M-M-R®II, Measles, Mumps, and Rubella Virus Vaccine
6 Recruiting Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Combined Measles-mumps-rubella (MMR) Vaccine in Subjects Four to Six Years of Age
Conditions: Rubella;   Mumps;   Measles
Interventions: Biological: Priorix®;   Biological: Merck's M-M-R®II, Measles, Mumps, and Rubella Virus Vaccine (also known as M-M-R Vax Pro™);   Biological: Kinrix®;   Biological: Varivax®
7 Withdrawn Safety Study of Measles-Mumps-Rubella-Varicella (MMRV) Vaccine, Priorix-Tetra™ in Children Living in the Philippines
Conditions: Mumps;   Rubella;   Measles;   Varicella
Interventions: Biological: Priorix-Tetra™;   Other: Safety data collection
8 Completed Immunogenicity and Safety of a Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases
Conditions: Measles;   Mumps;   Rubella;   Chickenpox
Intervention: Biological: Measles, Mumps, Rubella and Chickenpox (live vaccine)
9 Completed Immunogenicity and Safety of Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases
Conditions: Mumps;   Rubella;   Measles;   Varicella
Intervention: Biological: Measles, Mumps, Rubella and Chickenpox (live vaccine)
10 Completed Immunogenicity and Safety of a Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases
Conditions: Rubella;   Mumps;   Measles;   Chickenpox
Intervention: Biological: Measles, Mumps, Rubella and Chickenpox (live vaccine)
11 Not yet recruiting Study of Immunogenicity, Reactogenicity and Safety of the Combined Measles, Mumps and Rubella Vaccine Produced by Bio-Manguinhos/Fiocruz in Children 12-15 Months of Age, Followed by Tetraviral Vaccine in Children 15-18 Months.
Conditions: Measles;   Mumps;   Rubella;   Varicella
Interventions: Biological: MMR  Bio-Manguinhos;   Biological: MMR GlaxoSmithKline
12 Completed Immunogenicity, Safety of Measles-mumps-rubella-varicella Vaccine (MeMuRu-OKA) Compared to Priorix™ Given With Varilrix™
Conditions: Rubella;   Varicella;   Mumps;   Measles
Interventions: Biological: MeMuRu-OKA (study vac);   Biological: MMR, Varicella vacc (control)
13 Completed A Study of An Approved Vaccine at Mumps Expiry Potency in Healthy Children 12 to 18 Months of Age (V205C-007)(COMPLETED)
Conditions: Measles;   Mumps;   Rubella;   Varicella
Interventions: Biological: Comparator: M-M-R(TM) II, measles, mumps, and rubella virus vaccine live;   Biological: Comparator: VARIVAX(TM) Varicella Virus Vaccine Live (Oka-Merck)
14 Completed Serological Study in Children 12 to 23 Months Vaccinated With MMR (Measles, Mumps and Rubella)
Conditions: Mumps;   Rubella;   Measles
Intervention: Biological: MMR (Mumps, Measles and Rubella)
15 Active, not recruiting Evaluate Vaccine Agst Chickenpox & a Comb Vaccine Agst 4 Viral Childhood Diseases: Measles, Mumps, Rubella & Chickenpox
Conditions: Rubella;   Mumps;   Measles;   Chickenpox
Interventions: Biological: Priorix-tetra™;   Biological: Priorix™;   Biological: Varilrix™
16 Completed Study to Evaluate Frozen Versus Refrigerated MMRV (Combined Measles, Mumps, Rubella, and Varicella) Investigational Vaccine
Conditions: Measles;   Mumps;   Rubella;   Varicella
Intervention: Biological: V221, measles, mumps, rubella and varicella (Oka/Merck) virus vaccine live / Duration of Treatment: 12 weeks
17 Completed Immunogenicity, Safety of Measles-Mumps-Rubella-Varicella Vaccine (MeMuRu-OKA) Compared to Priorix™ Given With Varilrix™
Conditions: Measles;   Mumps;   Rubella;   Varicella
Interventions: Biological: MeMuRu-OKA (study vacc);   Biological: MMR, Varicella vacc (control)
18 Completed
Has Results
Safety, Tolerability, and Immunogenicity of Measles, Mumps, Rubella, and Varicella (MMRV) Vaccine Made With an Alternative Manufacturing Process (AMP)(V221-027)
Conditions: Measles;   Mumps;   Rubella;   Varicella
Interventions: Biological: MMRV (AMP);   Biological: MMRV (2006 process)
19 Completed Measles, Mumps, and Rubella (MMR) Immunity in College Students
Conditions: Measles;   Mumps;   Rubella
Intervention: Biological: MMR vaccine
20 Unknown  Making Decisions About the Measles-Mumps-Rubella Vaccine
Conditions: Measles;   Mumps;   Rubella;   MMR Vaccination
Intervention: Other: Behavioral: Computer-based tailoring system

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years